Portal Biotechnologies, Inc., a cell engineering platform company, announced a $5M pre-seed round led by Pear VC, with participation from Conscience VC and 10x Capital. Portal is implementing a simplified approach to intracellular delivery, focused on accelerating advances in RNA,…